Top in hem/onc: Blood type and COVID-19, racism in medicine

Two studies published in Blood Advances suggest that a person’s blood type could predict their risk for COVID-19 infection and likelihood of severe outcomes. It was the top story in hematology/oncology last week.

In another top story, Healio spoke with experts about racism in medicine and how to turn voices into action.

Read these and more top stories in hematology/oncology below:

Blood type may be linked to risk for COVID-19 infection, likelihood of severe outcomes

People with blood type O may be less likely to develop COVID-19 infection, and they may have a lower risk for severe outcomes if they contract the virus, according to results of two studies published in Blood Advances. Read more.

Addressing racism in medicine: Experts call on colleagues to turn talk into action

In a commentary published in Nature Medicine, experts provided guidance for physicians on how to discuss racism with their patients and work toward health equity. Read more.

Combating a killer: How to identify, address loneliness among patients with cancer

Extended loneliness can have grave effects for patients with cancer, and the COVID-19 pandemic has compounded the potential risks. Read more.

Addressing implicit bias in medicine requires multilevel approach

The “implicit bias movement” has not yet had the effect of substantially narrowing the gender gap in medicine, according to a presenter at the virtual Women in Medicine Summit. Read more.

One in three patients reports gaps in knowledge of cancer treatment adverse effects

A recent study showed that one in three adults undergoing cancer therapy may feel inadequately informed about treatment-related adverse effects they experience. Read more.